Molecular Cardiology in Clinical Practice
Michael R. Sanders, John B. Kostis
Springer Science & Business Media, Sep 30, 1999 - Medical - 226 pages
Cardiology is an area of great recent triumphs in pharmacological and surgical treatment, yet cardiovascular disease remains the leading cause of death and disability in the industrialized world. Coronary disease, heart failure, stroke and sudden arrhythmic cardiac death challenge both medical practitioners and scientists.
With the dawning of the new `molecular' era, there is an awakened hope that a more fundamental understanding of biologic processes may eventually lead to new progress in the prevention and treatment of these persistent and seemingly intransigent problems.
Molecular Cardiology in Clinical Practice brings together an outstanding panel of experts in cardiovascular disease who have been at the forefront of the application of molecular medicine to cardiology. Its intent is to help bridge the gap between modern medical practice and modern science, in the belief that an understanding of basic principles can lead to new insight into the problems of cardiac patients.
What people are saying - Write a review
We haven't found any reviews in the usual places.
INTRODUCTION TO MOLECULAR MEDICINE A CONTEMPORARY VIEW OF HEART FAILURE
MOLECULAR MECHANISMS OF MYOCARDIAL REMODELING
PATHOPHYSIOLOGY OF HEART FAILURE IN REGURGITANT VALVULAR DISEASES RELATION TO VENTRICULAR DYSFUNCTION AN...
CORONARY ATHEROTHROMBOSIS PATHOPHYSIOLOGY AND CLINICAL IMPLICATIONS
PREVENTION OF ATHEROSCLEROSIS ENDOTHELIAL FUNCTION CHOLESTEROL AND ANTIOXIDANTS
Physiologic and Pathophysiologic Effects of Angiotensin in the Heart and Vessel Wall
Other editions - View all
abnormal actin activation acute coronary syndromes amino acid angiotensin angiotensin II antagonists antibody antioxidant antiplatelet aortic apoptosis aspirin associated AT2 receptor atherosclerosis atherosclerotic plaque binding Biol blood pressure cardiac myocytes Cardiology cardiomyopathy cardiovascular cellular cholesterol Circulation Clin Invest clinical Coll Cardiol collagen contractile coronary artery disease coronary heart disease cytokines death decrease effect endothelial cells endothelial dysfunction endothelial function endothelium endothelium-dependent Engl enzyme estrogen extracellular Fas ligand Fas ligand expression fibrinogen fibroblasts gene expression glycoprotein GPIIb-IIIa growth factor human hypercholesterolemia hypertension hypertrophy increased induced inhibition inhibitor interaction ischemic L-arginine leukocyte lipid lipoprotein macrophages matrix mechanisms mediated membrane molecular monocyte myocardial infarction myocardium myosin nitric oxide synthase normal pathway patients peptide platelet protein rabbit reduced regurgitation response risk factors role sarcomere smooth muscle cells structure studies superoxide therapy thrombin ticlopidine tissue treatment trial unstable angina vascular smooth muscle vasodilation vessel wall vitro women